D Neil Granger

Title: D Neil Granger: Innovator in Pulmonary Drug Targeting

Introduction

D Neil Granger is a notable inventor based in Shreveport, Louisiana. He has made significant contributions to the field of medicine, particularly in the area of drug targeting for pulmonary vascular conditions. His innovative approach has the potential to improve treatment outcomes for patients suffering from various pulmonary diseases.

Latest Patents

Granger holds a patent for a method titled "Targeting and prolonging association of drugs to the luminal surface of the pulmonary vascular endothelial cells using antibodies that bind to ICAM-1." This patent outlines methods for administering a selected drug in combination with a non-internalizable ICAM-1 antibody. This approach is particularly beneficial for the dissolution of fibrin clots and the prevention of intravascular coagulation in the pulmonary vasculature.

Career Highlights

Granger is affiliated with the University of Pennsylvania, where he continues to advance research in pulmonary medicine. His work focuses on innovative methods to enhance drug delivery systems, which can lead to more effective treatments for patients.

Collaborations

Throughout his career, Granger has collaborated with esteemed colleagues such as Vladimir R Muzykantov and Juan Carlos Murciano. These partnerships have fostered advancements in the understanding and treatment of pulmonary vascular conditions.

Conclusion

D Neil Granger's contributions to the field of pulmonary drug targeting exemplify the impact of innovative thinking in medicine. His patented methods offer promising solutions for improving patient care in pulmonary health.